Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospitals, Labs, Pharma/Biotech), & Region - Global Forecast to 2030

The global AI in pathology market is expected to reach USD 347.39 million by 2030 from USD 107.43 million in 2025 at a high CAGR of 26.5% during the forecast period. According to the Personalized Medicine Coalition Report 2022, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases. Among the newly approved treatments are seven cancer drugs and three targeting other diseases and conditions. About 47% of these approved personalized therapies were indicated for treating cancer.

By use case, the drug discovery segment accounted for the largest share in 2024.

In 2024, the drug discovery segment accounted for the largest share of the AI in pathology market. Booming pharmaceutical & biotechnology R&D expenditure, the growing high-throughput screening & imaging, the increasing use of AI algorithms in pathology image analysis for the identification & classification of diseases, and the capability of AI to speed up the development of new therapeutics are expected to boost the market.

In 2024, the pharmaceutical & biopharmaceutical companies segment accounted for the largest share of the AI in pathology market, by end user.

In 2024, the pharmaceutical & biopharmaceutical companies segment accounted for the largest market share due to advancements in drug discovery & development and the increasing use of AI in pathology for drug toxicology testing. Biotechnology companies use AI-based digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.

North America held the largest market share in 2024.

In 2024, North America accounted for the largest market share in the AI in pathology market due to strong investment in research & development and advanced healthcare infrastructure, which enables the use of high-tech machinery. The large patient pool and data availability help create a large database, which can be used to train the AI for higher accuracy and efficiency.

The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players

The key players in the AI in pathology market include Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (US), Akoya Biosciences, Inc. (US), Aiforia Technologies Plc (Finland), Indica Labs Inc. (US), OptraScan (US), Ibex Medical Analytics Ltd. (Israel).

Research Coverage

The report estimates the market size and future growth potential of various market segments based on offering, neural network, use case, end user, function, and region. It also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a higher share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (development of CNNs and advanced AI models, Integration of AI into multiplex imaging, increasing cases of misdiagnoses in patients, benefits of AI-augmented telepathology, advancements in deep learning & image processing) restraints (high cost of digital pathology systems, limited AI expertise and varied regulatory guidelines for medical software, interoperability issues with legacy systems), opportunities (increasing demand for personalized medicine, integration of multi-omics data, and predictive analytics for disease progression) challenges (insufficient data for AI algorithms, data privacy, and ethical concerns, challenges associated with interpretability of AI models) influencing the growth of the AI in pathology market
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product & service launches in the AI in pathology market
• Market Development: Comprehensive information on the lucrative emerging markets by offering, neural network, function, use case, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players

Tables List

Table 1 Exchange Rates, 2021–2024

Table 2 Role Of Players In Market Ecosystem

Table 3 Regulatory Bodies, Government Agencies, And Other Organizations

Table 4 Us Fda: Medical Device Classification

Table 5 Us: Medical Device Regulatory Approval Process

Table 6 Canada: Medical Device Regulatory Approval Process

Table 7 Europe: Classification Of Ivd Devices

Table 8 Japan: Medical Device Classification Under Pmda

Table 9 China: Classification Of Medical Devices

Table 10 Indicative Pricing Analysis, By Offering

Table 11 Impact Of Porter’s Forces

Table 12 Jurisdiction Analysis Of Top Applicants In Ai In Pathology Market

Table 13 Key Patents In Ai In Pathology Market

Table 14 Influence Of Stakeholders On Buying Process, By End User (%)

Table 15 Key Buying Criteria, By End User

Table 16 Unmet Needs Of End Users

Table 17 Ai In Pathology Market: End User Expectations

Table 18 List Of Conferences And Events, 2025–2026

Table 19 Import Data For Hs Code 9011-compliant Products, By Country,

2020–2023 (Usd Thousand)

Table 20 Export Data For Hs Code 9011-compliant Products, By Country,

2020–2023 (Usd Million)

Table 21 Reciprocal Tariff Rates Adjusted By Us

Table 22 Tariff Rates For Ai In Pathology Products

Table 23 Expected Change In Prices And Their Impact On End User Products Due To Tariff Impact

Table 24 Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 25 Ai In Pathology Market For End-to-end Solutions, By Country/Region, 2023–2030 (Usd Million)

Table 26 Ai In Pathology Market For Niche Point Solutions, By Country/Region, 2023–2030 (Usd Million)

Table 27 Ai In Pathology Market For Technology, By Country/Region,

2023–2030 (Usd Million)

Table 28 Ai In Pathology Market For Hardware, By Type, 2023–2030 (Usd Million)

Table 29 Ai In Pathology Market For Hardware, By Country/Region,

2023–2030 (Usd Million)

Table 30 Ai In Pathology Market For Microscopes, By Country/Region,

2023–2030 (Usd Million)

Table 31 Ai In Pathology Market For Scanners, By Country/Region,

2023–2030 (Usd Million)

Table 32 Ai In Pathology Market For Storage Systems, By Country/Region,

2023–2030 (Usd Million)

Table 33 Ai In Pathology Market, By Neural Network, 2023–2030 (Usd Million)

Table 34 Ai In Pathology Market For Convolutional Neural Networks,

By Country/Region, 2023–2030 (Usd Million)

Table 35 Ai In Pathology Market For Generative Adversarial Networks,

By Country/Region, 2023–2030 (Usd Million)

Table 36 Ai In Pathology Market For Recurrent Neural Networks,

By Country/Region, 2023–2030 (Usd Million)

Table 37 Ai In Pathology Market For Other Neural Networks,

By Country/Region, 2023–2030 (Usd Million)

Table 38 Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 39 Ai In Pathology Market For Image Analysis, By Country/Region,

2023–2030 (Usd Million)

Table 40 Ai In Pathology Market For Diagnostics, By Country/Region,

2023–2030 (Usd Million)

Table 41 Ai In Pathology Market For Workflow Management, By Country/Region, 2023–2030 (Usd Million)

Table 42 Ai In Pathology Market For Data Management, By Country/Region, 2023–2030 (Usd Million)

Table 43 Ai In Pathology Market For Predictive Analytics, By Country/Region, 2023–2030 (Usd Million)

Table 44 Ai In Pathology Market For Cdss, By Country/Region,

2023–2030 (Usd Million)

Table 45 Ai In Pathology Market For Automated Report Generation,

By Country/Region, 2023–2030 (Usd Million)

Table 46 Ai In Pathology Market For Quality Assurance Tools,

By Country/Region, 2023–2030 (Usd Million)

Table 47 Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 48 Drug Discovery Applications For Ai In Pathology

Table 49 Ai In Pathology Market For Drug Discovery, By Type,

2023–2030 (Usd Million)

Table 50 Ai In Pathology Market For Drug Discovery, By Country/Region,

2023–2030 (Usd Million)

Table 51 Ai In Pathology Market For Target Identification & Selection,

By Country/Region, 2023–2030 (Usd Million)

Table 52 Ai In Pathology Market For Target Validation, By Country/Region, 2023–2030 (Usd Million)

Table 53 Ai In Pathology Market For Hit Identification & Prioritization,

By Country/Region, 2023–2030 (Usd Million)

Table 54 Ai In Pathology Market For Hit-to-lead Identification,

By Country/Region, 2023–2030 (Usd Million)

Table 55 Ai In Pathology Market For Lead Optimization, By Country/Region, 2023–2030 (Usd Million)

Table 56 Ai In Pathology Market For Candidate Selection & Validation,

By Country/Region, 2023–2030 (Usd Million)

Table 57 Ai In Pathology Market For Disease Diagnosis & Prognosis,

By Country/Region, 2023–2030 (Usd Million)

Table 58 Ai In Pathology Market For Clinical Workflow, By Country/Region, 2023–2030 (Usd Million)

Table 59 Ai In Pathology Market For Training & Education, By Country/Region, 2023–2030 (Usd Million)

Table 60 Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 61 Ai In Pathology Market For Pharmaceutical & Biopharmaceutical Companies, By Country/Region, 2023–2030 (Usd Million)

Table 62 Ai In Pathology Market For Hospitals & Reference Laboratories,

By Country/Region, 2023–2030 (Usd Million)

Table 63 Ai In Pathology Market For Academic & Research Institutes,

By Country/Region, 2023–2030 (Usd Million)

Table 64 Ai In Pathology Market, By Region, 2023–2030 (Usd Million)

Table 65 North America: Ai In Pathology Market, By Country,

2023–2030 (Usd Million)

Table 66 North America: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 67 North America: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 68 North America: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 69 North America: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 70 North America: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 71 Us: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 72 Us: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 73 Us: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 74 Us: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 75 Us: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 76 Canada: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 77 Canada: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 78 Canada: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 79 Canada: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 80 Canada: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 81 Europe: Ai In Pathology Market, By Country/Region,

2023–2030 (Usd Million)

Table 82 Europe: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 83 Europe: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 84 Europe: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 85 Europe: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 86 Europe: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 87 Uk: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 88 Uk: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 89 Uk: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 90 Uk: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 91 Uk: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 92 Germany: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 93 Germany: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 94 Germany: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 95 Germany: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 96 Germany: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 97 France: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 98 France: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 99 France: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 100 France: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 101 France: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 102 Italy: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 103 Italy: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 104 Italy: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 105 Italy: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 106 Italy: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 107 Spain: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 108 Spain: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 109 Spain: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 110 Spain: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 111 Spain: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 112 Rest Of Europe: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 113 Rest Of Europe: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 114 Rest Of Europe: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 115 Rest Of Europe: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 116 Rest Of Europe: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 117 Asia Pacific: Ai In Pathology Market, By Country/Region,

2023–2030 (Usd Million)

Table 118 Asia Pacific: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 119 Asia Pacific: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 120 Asia Pacific: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 121 Asia Pacific: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 122 Asia Pacific: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 123 China: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 124 China: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 125 China: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 126 China: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 127 China: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 128 Japan: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 129 Japan: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 130 Japan: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 131 Japan: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 132 Japan: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 133 Japan: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 134 India: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 135 India: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 136 India: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 137 India: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 138 India: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 139 Rest Of Asia Pacific: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 140 Rest Of Asia Pacific: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 141 Rest Of Asia Pacific: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 142 Rest Of Asia Pacific: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 143 Rest Of Asia Pacific: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 144 Latin America: Ai In Pathology Market, By Country/Region,

2023–2030 (Usd Million)

Table 145 Latin America: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 146 Latin America: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 147 Latin America: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 148 Latin America: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 149 Latin America: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 150 Brazil: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 151 Brazil: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 152 Brazil: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 153 Brazil: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 154 Brazil: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 155 Mexico: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 156 Mexico: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 157 Mexico: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 158 Mexico: Ai In Pathology Market, By Use Case, 2023–2030 (Usd Million)

Table 159 Mexico: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 160 Rest Of Latin America: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 161 Rest Of Latin America: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 162 Rest Of Latin America: Ai In Pathology Market, By Neural Network, 2023–2030 (Usd Million)

Table 163 Rest Of Latin America: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 164 Rest Of Latin America: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 165 Middle East & Africa: Ai In Pathology Market, By Region,

2023–2030 (Usd Million)

Table 166 Middle East & Africa: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 167 Middle East & Africa: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 168 Middle East & Africa: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 169 Middle East & Africa: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 170 Middle East & Africa: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 171 Gcc Countries: Ai In Pathology Market, By Offering,

2023–2030 (Usd Million)

Table 172 Gcc Countries: Ai In Pathology Market, By Function,

2023–2030 (Usd Million)

Table 173 Gcc Countries: Ai In Pathology Market, By Neural Network,

2023–2030 (Usd Million)

Table 174 Gcc Countries: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 175 Gcc Countries: Ai In Pathology Market, By End User,

2023–2030 (Usd Million)

Table 176 Rest Of Middle East & Africa: Ai In Pathology Market, By Offering, 2023–2030 (Usd Million)

Table 177 Rest Of Middle East & Africa: Ai In Pathology Market, By Function, 2023–2030 (Usd Million)

Table 178 Rest Of Middle East & Africa: Ai In Pathology Market, By Neural Network, 2023–2030 (Usd Million)

Table 179 Rest Of Middle East & Africa: Ai In Pathology Market, By Use Case,

2023–2030 (Usd Million)

Table 180 Rest Of Middle East & Africa: Ai In Pathology Market, By End User, 2023–2030 (Usd Million)

Table 181 Overview Of Strategies Deployed By Key Companies

Table 182 Ai In Pathology Market: Degree Of Competition

Table 183 Offering Footprint

Table 184 Use Case Footprint

Table 185 End User Footprint

Table 186 Region Footprint

Table 187 Ai In Pathology Market: Detailed List Of Key Startups/Smes

Table 188 Ai In Pathology Market: Competitive Benchmarking Of Key Startups/Smes

Table 189 Ai In Pathology Market: Product/Service Launches & Approvals, January 2021–april 2025

Table 190 Ai In Pathology Market: Deals, January 2021–april 2025

Table 191 Ai In Pathology Market: Other Developments, January 2021– April 2025

Table 192 Koninklijke Philips N.V.: Company Overview

Table 193 Koninklijke Philips N.V.: Products/Services Offered

Table 194 Koninklijke Philips N.V.: Deals, January 2021–april 2025

Table 195 F. Hoffmann-la Roche Ltd.: Company Overview

Table 196 F. Hoffmann La Roche Ltd.: Products/Services Offered

Table 197 F. Hoffmann-la Roche Ltd.: Product/Service Launches & Approvals, January 2021−march 2025

Table 198 F. Hoffmann-la Roche Ltd.: Deals, January 2021−march 2025

Table 199 Hologic, Inc.: Company Overview

Table 200 Hologic, Inc.: Products/Services Offered

Table 201 Hologic, Inc.: Product/Service Launches & Approvals, January 2021−april 2025

Table 202 Akoya Biosciences, Inc.: Company Overview

Table 203 Akoya Biosciences, Inc.: Product/Services Offered

Table 204 Akoya Biosciences, Inc.: Deals, January 2021−april 2025

Table 205 Aiforia Technologies Plc: Company Overview

Table 206 Aiforia Technologies Plc: Product/Services Offered

Table 207 Aiforia Technologies Plc: Deals, January 2021−april 2025

Table 208 Indica Labs Inc.: Company Overview

Table 209 Indica Labs Inc.: Products/Services Offered

Table 210 Indica Labs Inc.: Product/Service Launches & Approvals,

January 2021−april 2025

Table 211 Indica Labs Inc.: Deals, January 2021−april 2025

Table 212 Indica Labs Inc.: Expansions, January 2021–april 2025

Table 213 Optrascan: Company Overview

Table 214 Optrascan: Products/Services Offered

Table 215 Optrascan: Other Developments, January 2021–april 2025

Table 216 Ibex Medical Analytics Ltd.: Company Overview

Table 217 Ibex Medical Analytics Ltd.: Products/Services Offered

Table 218 Ibex Medical Analytics Ltd.: Product/Service Launches & Approvals, January 2021–april 2025

Table 219 Ibex Medical Analytics Ltd: Deals, January 2021–april 2025

Table 220 Mindpeak Gmbh: Company Overview

Table 221 Mindpeak Gmbh: Products/Services Offered

Table 222 Mindpeak Gmbh: Product/Service Launches & Approvals,

January 2021–april 2025

Table 223 Mindpeak Gmbh: Deals, January 2021–april 2025

Table 224 Mindpeak Gmbh: Other Developments, January 2021–april 2025

Table 225 Tribun Health: Company Overview

Table 226 Tribun Health: Products/Services Offered

Table 227 Tribun Health: Deals, January 2021–april 2025

Table 228 Techcyte, Inc.: Company Overview

Table 229 Techcyte, Inc.: Products/Services Offered

Table 230 Techcyte, Inc.: Product/Service Launches & Approvals,

January 2021–april 2025

Table 231 Techcyte, Inc.: Deals, January 2021–april 2025

Table 232 Techcyte, Inc.: Other Developments, January 2021–april 2025

Table 233 Deep Bio Inc.: Company Overview

Table 234 Deep Bio Inc.: Products/Services Offered

Table 235 Deep Bio Inc.: Deals, January 2021–april 2025

Table 236 Lumea Inc.: Company Overview

Table 237 Lumea Inc.: Products/Services Offered

Table 238 Lumea Inc.: Deals, January 2021–april 2025

Table 239 Visiopharm: Company Overview

Table 240 Visiopharm: Products/Services Offered

Table 241 Visiopharm: Product/Service Launches & Approvals,

January 2021–april 2025

Table 242 Visiopharm: Expansions, January 2021– April 2025

Table 243 Aetherai: Company Overview

Table 244 Aetherai: Products/Services Offered

Table 245 Aetherai: Deals, January 2021– April 2025

Table 246 Aiosyn: Company Overview

Table 247 Aiosyn: Products/Services Offered

Table 248 Aiosyn: Product/Service Launches & Approvals,

January 2021–april 2025

Table 249 Aiosyn: Deals, January 2021–april 2025

Table 250 Aiosyn: Other Developments, January 2021–april 2025

Table 251 Paige Ai, Inc.: Company Overview

Table 252 Paige Ai, Inc.: Products/Services Offered

Table 253 Paige Ai, Inc.: Product/Service Launches & Approvals,

January 2021– April 2025

Table 254 Paige Ai, Inc.: Deals, January 2021–april 2025

Table 255 Paige Ai, Inc.: Other Developments, January 2021–april 2025

Table 256 Proscia, Inc.: Company Overview

Table 257 Proscia, Inc.: Products/Services Offered

Table 258 Proscia, Inc.: Product/Service Launches & Approvals,

January 2021–april 2025

Table 259 Proscia, Inc.: Deals, January 2021–april 2025

Table 260 Proscia, Inc.: Other Developments, January 2021–april 2025

Table 261 Pathai, Inc.: Company Overview

Table 262 Pathai, Inc.: Products/Services Offered

Table 263 Pathai, Inc.: Product/Service Launches & Approvals,

January 2021–april 2025

Table 264 Pathai, Inc.: Deals, January 2021–april 2025

Table 265 Tempus Labs, Inc.: Company Overview

Table 266 Tempus Labs, Inc.: Products/Services Offered

Table 267 Tempus Labs, Inc.: Product/Service Launches & Approvals,

January 2021–april 2025

Table 268 Konfoong Bioinformation Tech Co., Ltd.: Company Overview

Table 269 Domore Diagnostics As: Company Overview

Table 270 Qritive: Company Overview

Table 271 Deeppath: Company Overview

Table 272 4d Path Inc.: Company Overview

Figures List

Figure 1 Research Design

Figure 2 Key Primary Sources

Figure 3 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region

Figure 4 Market Size Estimation Process

Figure 5 Key Insights From Industry Experts

Figure 6 Bottom-up Approach: End User Spending On Ai In Pathology

Figure 7 Ai In Pathology Market: Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges (2025–2030)

Figure 8 Cagr Projections: Supply-side Analysis

Figure 9 Top-down Approach

Figure 10 Data Triangulation Methodology

Figure 11 Ai In Pathology Market, By Offering, 2025 Vs. 2030 (Usd Million)

Figure 12 Ai In Pathology Market, By Neural Network, 2025 Vs. 2030 (Usd Million)

Figure 13 Ai In Pathology Market, By Use Case, 2025 Vs. 2030 (Usd Million)

Figure 14 Ai In Pathology Market, By End User, 2025 Vs. 2030 (Usd Million)

Figure 15 Ai In Pathology Market: Geographic Snapshot

Figure 16 Development Of Convolutional Neural Networks (Cnns) And Ai Learning Models To Propel Market

Figure 17 North America To Lead Market During Forecast Period

Figure 18 Pharmaceutical & Biopharmaceutical Companies Segment And China Accounted For Significant Share In 2024

Figure 19 India To Register Highest Growth During Forecast Period

Figure 20 Ai In Pathology Market: Drivers, Restraints,

Opportunities, And Challenges

Figure 21 Healthcare Breaches Reported To Us Department Of

Health And Human Services (September 2024)

Figure 22 Trends & Disruptions Impacting Customer Business

Figure 23 Ecosystem Analysis

Figure 24 Value Chain Analysis

Figure 25 Europe: Ivdr Timeline

Figure 26 Porter’s Five Forces

Figure 27 Number Of Patents Published, January 2017−april 2025

Figure 28 Number Of Patent Documents, By Jurisdiction

Figure 29 Top Patent Applicants And Owners (Companies/Institutions),

January 2017–april 2025

Figure 30 Influence Of Stakeholders On Buying Process, By End User

Figure 31 Key Buying Criteria, By End User

Figure 32 Funding Activities In Ai In Pathology Market

Figure 33 Market Potential Of Ai/Generative Ai In Pathology

Figure 34 Import Data For Hs Code 9011-compliant Products, By Country,

2020–2023 (Usd)

Figure 35 Export Data For Hs Code 9011-compliant Products, By Country,

2020–2023 (Usd Thousand)

Figure 36 North America: Ai In Pathology Market Snapshot

Figure 37 Asia Pacific: Ai In Pathology Market Snapshot

Figure 38 Revenue Analysis Of Key Players, 2020−2024 (Usd Million)

Figure 39 Ai In Pathology Market: Market Share Analysis (2024)

Figure 40 Ai In Pathology Market: Company Evaluation Matrix (Key Players), 2024

Figure 41 Ai In Pathology Market: Company Footprint

Figure 42 Ai In Pathology Market: Company Evaluation Matrix

(Startups/Smes), 2024

Figure 43 Ev/Ebitda Of Key Vendors

Figure 44 Ytd Price Total Return And 5-year Stock Beta Of

Ai In Pathology Vendors

Figure 45 Brand/Product Comparison

Figure 46 Koninklijke Philips N.V.: Company Snapshot (2024)

Figure 47 F. Hoffmann-la Roche Ltd.: Company Snapshot (2024)

Figure 48 Hologic, Inc.: Company Snapshot (2024)

Figure 49 Akoya Biosciences, Inc.: Company Snapshot (2023)

Figure 50 Aiforia Technologies Plc: Company Snapshot (2024)

Figure 51 Tempus: Company Snapshot (2024)